Hers Review

What Is Hers?

Hers offers one of the most affordable entry points to GLP-1 weight loss treatment, with monthly plans starting at just $69. Their platform provides access to a wide range of treatment options including Ozempic®, Wegovy®, Mounjaro®, and Zepbound®. With $0 membership fees and 24/7 access to licensed providers through their app, it's a convenient option for busy individuals.

How Does Hers Work?

Here's what the process actually looks like with Hers, step by step:

1. 1
   Online assessment: A well-designed intake covering weight history, medical conditions, and current medications.
2. 2
   Provider review: A licensed provider evaluates your file and determines which medication, if any, is appropriate.
3. 3
   Plan selection: You choose a plan length from one to twelve months. Longer terms cost less monthly but are prepaid.
4. 4
   Discreet delivery: Medication ships in unmarked packaging — a feature Hers has always taken seriously.
5. 5
   24/7 provider access: Messaging with licensed providers at any hour through the app, which is genuinely useful during titration.

What the 2026 compounded exit means for you

In March 2026, following heightened FDA scrutiny of compounded-GLP-1 marketing — including a wave of warning letters issued to telehealth companies that month — Hims and Hers stopped advertising compounded GLP-1s and moved to FDA-approved branded medication only.

If you used Hers for compounded semaglutide previously, that product is gone. What replaced it is Wegovy, Zepbound, and the newer oral GLP-1 options, which are real FDA-approved medicines with full trial data behind them.

The honest trade-off: safety and regulatory clarity improved, and cash-pay affordability got worse. Anyone comparing today's Hers to a memory of $199 compounded semaglutide should re-run the numbers.

The women's-health framing is substance, not just branding

Hers is Hims' counterpart brand, and the weight-loss program reflects an orientation toward conditions and questions that disproportionately affect women. PCOS, perimenopausal weight change, and the interaction between GLP-1s and hormonal contraception come up routinely in the intake rather than being treated as edge cases.

That's clinically relevant. GLP-1s can affect oral contraceptive absorption through delayed gastric emptying — a genuine interaction that a general-purpose intake may not surface. Tirzepatide's labeling specifically addresses this.

Men can use Hims for the equivalent program. The distinction is mostly about which questions the intake asks and how the content is written, not about who's eligible.

Plan length and the prepayment question

Hers offers plan terms from one to twelve months, with the monthly rate dropping as you commit longer. This is common in the category and deserves scrutiny.

A twelve-month prepaid plan at a discount is a good deal if you complete twelve months. It's a poor deal if the medication doesn't agree with you in week four. Roughly a fifth of patients discontinue GLP-1 therapy early because of side effects, and prepayment converts that clinical risk into a financial loss.

Our general advice: start with the shortest term. Move to a longer plan at month three, once you know you tolerate the medication. The discount you forgo in the first quarter is cheap insurance.

App quality and 24/7 access

The Hers app is among the best in the category — clean, fast, and organized around the things you actually do repeatedly. Refill management and provider messaging both work without friction.

24/7 provider messaging is more than a marketing line. GLP-1 side effects don't respect business hours, and being able to ask at 11pm whether escalating nausea warrants holding a dose is a real advantage over programs with a 48-hour response window.

Response quality varies with who picks up your message. It's a large operation and you won't have a consistent clinician relationship.

Treatment Options

Hers Pricing

Starting at $69/month

As of March 2026, Hims and Hers no longer advertise compounded GLP-1s and sell only FDA-approved branded medication — Wegovy, Zepbound, and the newer oral GLP-1 options. That's better for safety and worse for your wallet. The $69 entry price is real, but it is the membership, not the drug.

Pricing may vary based on your specific treatment plan and medication selection. Contact Hers directly for the most current pricing information.

Who Should Use Hers?

Women looking for affordable, flexible weight loss treatment options

• Women who want a program that treats PCOS and perimenopausal weight change as core cases rather than exceptions
• Anyone who wants brand-name FDA-approved medication through a polished platform
• People who value 24/7 provider messaging during titration
• Patients who want discreet, unmarked delivery

Who Is Hers Not For?

• Anyone specifically seeking compounded semaglutide or tirzepatide — no longer offered
• Cash-pay patients optimizing purely for the lowest total monthly cost
• People who want a consistent one-to-one clinician relationship
• Anyone who is pregnant, planning pregnancy, or breastfeeding
• People with a personal or family history of medullary thyroid carcinoma or MEN2, or a history of pancreatitis — discuss these with your doctor

Hers — Frequently Asked Questions

How Hers Compares

If Hers isn't the right fit, these are the alternatives we'd point you to first — and why.